| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
|
Rippel, Noa
|
|
|
119 |
C |
p.
|
article
|
| 2 |
Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms
|
De Marchi, Federico
|
|
|
119 |
C |
p.
|
article
|
| 3 |
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center
|
Othman, Tamer
|
|
|
119 |
C |
p.
|
article
|
| 4 |
Editorial Board
|
|
|
|
119 |
C |
p.
|
article
|
| 5 |
Epidemiologic evaluation of clinical outcomes in ethnic minorities with myelodysplastic syndromes
|
Molina, Alfonso
|
|
|
119 |
C |
p.
|
article
|
| 6 |
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine
|
Kim, Kunhwa
|
|
|
119 |
C |
p.
|
article
|
| 7 |
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax
|
Chojecki, Aleksander L.
|
|
|
119 |
C |
p.
|
article
|
| 8 |
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
|
Lucijanic, Marko
|
|
|
119 |
C |
p.
|
article
|
| 9 |
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study
|
Frisch, Avraham
|
|
|
119 |
C |
p.
|
article
|
| 10 |
2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patients
|
Bradwell, Susie
|
|
|
119 |
C |
p.
|
article
|
Journal description